Trial · NCT02980276
Registered outcomes34
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 34
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Primary Composite Outcome | Enrolment through delivery, an average of 16 weeks. | The primary efficacy outcome was achieved if any participant experienced: * Insulin initiation * Fasting glucose value \>5.1 mmol/l at 32weeks or 38 weeks gestation. |
| Primary | Insulation of Insulin | Enrolment through delivery, an average of 16 weeks. | Initiation of insulin treatment at any time up to delivery. |
| Secondary | Time to Insulin Initiation | Time to Insulin Initiation, from date of randomization until the date of delivery, an average of 16 weeks.. | Time to Insulin Initiation, from date of randomization until the date of delivery. |
| Secondary | Insulin Initiated | Enrolment through delivery, an average of 16 weeks. | Whether or not insulin was initiated at any time during the study. |
| Secondary | Fasting Hyperglycemia | Measured at 32 and 38 weeks' gestation. | Number of women with fasting hyperglycemia at 32wks or at 38wks gestation. |
| Secondary | Insulin Dose Required | Enrolment through delivery, an average of 16 weeks. | Insulin dose required in any participant requiring insulin. |
| Secondary | Gestational Weight Gain | Enrolment through delivery, an average of 16 weeks. | Change in weight (kg) from randomization until last visit before delivery |
| Secondary | Postpartum Impaired Fasting Glucose | 12 weeks post-partum | Impaired fasting glucose at 12 weeks postpartum |
| Secondary | Postpartum Impaired Glucose Tolerance | 12 weeks postpartum | |
| Secondary | Postpartum Metabolic Syndrome | 12 weeks postpartum | |
| Secondary | Gestational Age at Delivery | At delivery, an average of 16 weeks after enrolment | |
| Secondary | Mode of Delivery - Cesarian Delivery | At delivery, an average of 16 weeks after enrolment | Delivered by Cesarian section. |
| Secondary | Mode of Delivery - Emergency Cesarian Section | At delivery, an average of 16 weeks after randomization. | Among those having cesarian section, count of emergency procedures. |
| Secondary | Mode of Delivery - Induced | At time of labor, an average of 16 weeks after enrolment. | Labor induced. |
| Secondary | Maternal Morbidity - Pregnancy-induced Hypertension | From enrolment through 6 weeks postpartum, an average of 22 weeks. | |
| Secondary | Maternal Morbidity - Pre-eclampsia | Enrolment through 6 weeks postpartum, an average of 22 weeks. | Pre-eclampsia diagnosed during study participation |
| Secondary | Maternal Morbidity - Antepartum Hemorrhage | From enrolment through delivery, an average of 16 weeks. | Any vaginal bleeding prior to delivery |
| Secondary | Maternal Morbidity - Postpartum Hemorrhage | From delivery through 6 weeks postpartum. | |
| Secondary | Birthweight | At birth | |
| Secondary | Neonatal Head Circumference | At birth |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02980276/registered